• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. Pakistan Journal of Biological Sciences
  2. Vol 26 (1), 2023
  3. 1-14
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

Pakistan Journal of Biological Sciences

Year: 2023 | Volume: 26 | Issue: 1 | Page No.: 1-14
DOI: 10.3923/pjbs.2023.1.14
crossmark

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
Review Article

Oral candidiasis of tobacco smokers: A literature review

Mohamed A. El-Sakhawy Mohamed A. El-Sakhawy's LiveDNA, Abd El Raheim M. Donia, Abdel Nasser A. Kobisi, Walid Kamal Abdelbasset Walid Kamal Abdelbasset's LiveDNA, Ahmad M. Saleh, Ateya Megahed Ibrahim and Rasha M. Negm

ABSTRACT


The mouth is a vital point of entry into the human body, the health of the mouth entails mental, physical as well as social well-being. Studying diseases, microbiota and environmental conditions of the mouth is important to maintain oral health and all body. The smoke of tobacco cigarettes is one of the worst habits that affect the health of the mouth and the body. Therefore, this review has been conducted to study the effect of smoking on the balance of the oral microbiota and the opportunistic organisms, one of the most important of them Candida. Although a few studies have found that cigarette smoking does not influence carriage by Candida significantly. However, most of the studies had results completely contrary to that, smoking cigarettes affect Candida pathogenic characteristics such as a transition from yeast to hyphal form, biofilm formation and, virulence-related gene expressions. Tobacco is not only an inducer of the transition process but it considers an excellent medium for this process. Furthermore, smoking was significantly associated with Candida pathogenicity in patients with clinically suspected oral leukoplakia and smoking worsens oral candidiasis and dampens epithelial cell defense response. Nicotine significantly altered the composition and proportion of yeast cells, as well as the extracellular polysaccharide amounts which increase biofilm matrix and thickness which could promote oral candidiasis. Smoking has the potential to alter the oral condition and cause severe oxidative stress, thereby damaging the epithelial barrier of the mouth. These oxidative molecules during smoking activate epithelial cells proteins called oxidative stress-sensing proteins. If some of these proteins induced, widely thought to have anti-inflammatory properties, inhibit the secretion of pro-inflammatory cytokines and are linked to inflammation and oxidative stress is thought to be a possible therapeutic objective and a crucial regulator for smoking-related oral diseases and mouth candidiasis for instance leukoplakia. Also, it is transported into the cell nucleus in the existence of additional electrophilic chemicals to activate antioxidant enzyme gene expression. Therefore, smoking cigarettes destroys oral health and consequently destroys the health of the whole body.
PDF Abstract XML References Citation
Copyright: © 2023. This is an open access article distributed under the terms of the creative commons attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

How to cite this article

Mohamed A. El-Sakhawy, Abd El Raheim M. Donia, Abdel Nasser A. Kobisi, Walid Kamal Abdelbasset, Ahmad M. Saleh, Ateya Megahed Ibrahim and Rasha M. Negm, 2023. Oral candidiasis of tobacco smokers: A literature review. Pakistan Journal of Biological Sciences, 26: 1-14.

DOI: 10.3923/pjbs.2023.1.14

URL: https://scialert.net/abstract/?doi=pjbs.2023.1.14

INTRODUCTION


Mouth is a vital point of entry into the human body, consists of both soft (tongue and the gingival mucosa) and hard (hard palate, teeth and bone) tissues. These tissue structures are essential for oral health. Oral health entails mental, physical as well as social well-being1.

Microorganisms can be found in every aspect of human life and have an impact on it. The human mouth microbiota is thought to be 2nd most complicated after a colon and it is more diverse than mucosal sites as well as human skin. There are numerous habitats in the human mouth cavity. The synergy and interaction of various oral microbes protect the human body from unwanted stimulation from outside. An imbalance of normal microbial flora contributes to oral and systemic diseases. Or, to put it another way, mouth microbiomes play a critical role in the health of humans and the microbiological community2-6. This normal mouth microbiota is made up of interactive, complex communities of microorganisms and nutrients, mostly bacteria that live in biofilms on oral cavity surfaces4-9. Almost microbial biofilm properties may actually preserve or improve oral health, in addition, to defending against the possible invasive pathogenic microbes, while others may enhance the virulence of possible microbes that are harmful and reduce the effectiveness of antimicrobials9-11.

Microbiota in the mouth has been associated with a variety of oral diseases. Recent evidence suggests that the microbiota of the mouth is closely linked to human physical conditions for instance cancer, diabetes and obesity. Microbiota of the mouth will become one of the modern objectives aimed to achieve human physical health in the future12. Studies on oral microbiomes and their relationships with the other microbiomes in various human sites of the body and health conditions are crucial in our understanding of our bodies and how to improve health in human beings3. Alternatively, the microenvironment in the oral cavity varies in microbial composition and is influenced by hosts, external environmental variables and complex signaling. Undoubtedly, human health can be affected by the health state that affects the composition of oral bacteria, as well as microbial community destruction, which is linked to systemic diseases13. Antibiotics-induced changes in bacterial balance as the main component of oral microbiota, these bacteria may be crucial and upper hand in causing candidiasis and other human fungal infection, for instance, using of antibacterial antibiotics and immunosuppression (systemic or local) drugs make most infections especially Candidal and other fungal infection may require this to spread2,9. The microbiota in the mouth is a vital basic human microbiota component. Microflora balance disturbances occurring in the host oral cavity may be altered by Candida because it is an opportunistic fungus that remains harmless until this state changes for various reasons12,14. Yeast Candida is an organism that is frequently found on the mucosal surfaces of healthy people's genitourinary tracts, digestive systems and mouths. This yeast has the potential to be an opportunistic pathogen15,16.

The smoke of tobacco cigarettes contains over four thousand chemicals, most of which are toxic, of which fifty are extremely cariogenic as well as contributing to dental caries17. Although several studies have found that cigarette smoking has no significant effect on Candida carriage18-20, other studies have found that tobacco smoking significantly increases its prevalence21,22. Moreover additional studies have suggested that smoking, whether alone or in combination with other factors, maybe a significant risk factor for candidiasis in the mouth, this connection or its pathogenicity effects on Candida in the mouth is far from resolved. The precise mechanism by which cigarette or cigar smoke may affect dental candidal carriage is fully unknown23.

Therefore, the goal of this review was to explain the oral microbiota, especially candidal mycobiota (fungal microbiota), oral candidiasis, factors that affect oral candidiasis, interactions between commensal Candida and cigarette smokers and mechanisms by which oral carriage of Candida may be influenced by tobacco cigarette smoking.

Human oral microbiota: Sometimes, the oral cavity is referred to as a mirror that reflects a people’s health. The human mouth cavity is a unique environment that involves diverse microbial habitats. For example, the tongue, hard and soft palate, buccal mucosa and teeth, which make up a diverse ecological system with a lot of different species24.

Oral microbiota is not like gut microbiota in changes of bacterial types. Environment and diet have a great influence on the gut microbiota but the same causes have a small effect on oral bacteria25. In the previous data collected about oral the human microbiome, about 150 genera, 400 oral taxa, 700 species and over 1300 microorganism strains26. Only prokaryotes in the buccal cavity contain about 700 species3. Saliva contains about more than 108 microorganisms/mL, which have been detected27. There are many microorganisms in the mouth, most of them bacteria, then fungi and then viruses. These bacteria are mostly Firmicutes, Bacillus, Proteobacteria and Actinomycetes28,29. The majority of bacterial microflora residents in the mouth are streptococci30. From oral bacterial classification, Streptococcus spp., are separated into four groups, mitis-group, anginosus-group, sanguinis-group and mutans-group31,32. The members of the salivarius-group are associated with tongue mucosal surfaces and human mouth vestibular mucosa. The mutans-group is one of the causative agents of dental caries while anginosus-group members are frequently etiological agents of internal organs abscesses and it is also linked to the development of purulent human disease31-33. On the other hand, mitis-group members consider opportunistic bacterial pathogens linked to endocarditis infections32.

Gomez et al.34 found that bacteria are the primary constituents of the oral microbiota. Lactobacillus spp., Staphylococcus spp., Porphyromonas gingivalis and Streptococcus mutans are examples of common oral bacteria. The main constituent of oral bacterial microbiota is S. mutans which is considered an etiological agent disease of teeth hard tissues, the highest incidence among oral diseases and a major component of plaque on the teeth35,36.

Whereas one of the most periodontal pathogens of Gram-negative anaerobic bacteria is P. gingivalis. If P. gingivalis is not treated, the gums can fall off the teeth. The lactic acid in large amounts is produced from sugar fermentation by Lactobacillus spp., which can easily cause caries. On the other hand, Lactobacillus spp., consider a probiotic in yogurt which has benefits to the host’s health37.

Human oral viruses, mostly phages, consider one of the oral microbiota members38. Throughout life, the oral type phage remains constant39. Other non-original viruses may appear in the oral cavity when certain diseases are present in the human body, mumps and HIV are two of these viruses40,41.

In general, different studies from various countries concluded that microbial compositions of healthy Oral microbiota are similar. There are eighty-five fungal species to be found in oral microbiota, one of the most crucial fungi of oral microbiota is Candida spp.42. If the oral microbiota is balanced, Candida doesn’t invade oral tissues but if the balance changes, Candida becomes opportunistic, in addition, Candida interacts with Streptococcus to form biofilm as a pathogenic role43. Candida species are oral normal microflora that is most commonly found in the dorsum (end part) of the tongue but can also be found on the digestive tract and vagina44.

Oral mycosis: There are many fungal contaminants and etiological agents isolated from cases infected by oral cavity mycoses Acremonium spp., Aspergillus spp., Cryptococcus spp., Candida spp., Fusarium spp., Malassezia spp., Rhodotorula spp. and Trichosporon spp. On the other hand, Candida spp., as well as Cryptococcus sp., are the main factor in primary infections by colonization, especially Candida spp. In the case of biofilm formation in the mouth, usually, spores of more than one microbe come or accumulate on the epithelial cells’ upper part and form a suitable environment for growth and microbial survival45. Colonization of oral cavity candidiasis can occur not only by Albicans but also by non-albicans e.g. C. glabrata, C. guilliermondii, C. krusei, C. lusitaniae and C. parapsilosis but CA is the most common and virulence species46,47.

Candida spp. is one of the mycobiota, in immunocompromised individuals, it can cause oral candidiasis in oral mucosa according to an overgrowth in the site of infection2,9. Xu and Dongari-Bagtzoglou2 noted that “A functional immunodeficiency in the Th17 CD4+ cell subset is the underlying link that connects all known systemic conditions of the host related to mouth candidiasis”.

Oral candidiasis: Out of two hundred known Candidal spp., only forty species can cause Candidal diseases but remain CA is the most commonly known species that cause infection44.

Oral mycoses is a microbial-oriented efficient disease that was probably initially started by biofilm formation of the mouth lining tissues and its surrounding. Several studies concluded that Aspergillus spp. and Candida spp., are regularly isolated fungal species48. The percentage of presence of Candida spp., in the oral cavity is equivalent to 53% of mankind as a normal microbiota, 80% of isolated Candida is albicans species that it can colonize alone or with other microbial species49.

Transformation of candidal pathogenicity from commensalism is based on the intervention of various predisposing factors that alter the oral cavity microenvironment and favor the appearance of opportunistic infection. Candida albicans (CA) is a highly invasive and adaptive microbe among other species of Candida which it can cause mycosis at various anatomical sites. In recent years, we have gained an improved comprehension of the complex interlinkage between CA strains and hosts but after all these papers there are still significant gaps in our understanding of albicans pathogenicity, albican’s role in human microbiota and conversion between two states as well as responses of host immune system50.

Generally, Candida albicans (CA) live and colonize up to sixty percent of healthy people as a commensal yeast therefore the conversion to opportunistic candidiasis is easy51. The oral cavity is the house of an exclusive complexed ecosystem called oral microbiota which is constructed of hundreds of fungal and bacterial species, one of the very important microbiota is CA. In addition, that CA is the most common opportunistic ubiquitous yeast which is the most etiological agent of invasive and mucosal human fungal infections52,53.

The virulence factors of C. albicans: One of the most important virulence factors of CA strains is the capability to change or switch to a pseudohyphal shape from a yeast shape. Many factors can induce this transition e.g. glucose, serum, CO2, proline, N-acetylglucosamine, starvation and temperature (37°C)54-57. During candidiasis development, CA begins to adhere to tissues as well as invade these tissues. This adhesion is promoted by yeast cell wall proteins58,59. Cell wall Candida contains mannans, glucans, chitins and glycoproteins60-62. The scientists discovered three genes of CA, encoding different chitin synthases (CHS 3, 2 and 1). The production of an amount of chitin is reliant on cultural conditions. Preferentially, two of three genes (CHS3 and CHS2) are expressed under hyphal culture conditions63,64, while CHS1gene level continued as a small level in two forms of hyphae as well as yeast65. Remarkably, CHS1p was found to be necessary for virulence and cell integrity65. Any defects in chitin proteins by mutation make mutant yeast cells less dangerous than the parent strain in the experimental animal model. Consequently, with a high chitin level, CA can evade the effects of cigarette smoke and the immune system of the host63.

Commensal fungi CA colonized healthy individuals and a pathogen of immunocompromised and immunocompetent patients with compromised barriers to spread. Adaptation and regulation to the microenvironment of the host are involved in both commensal and pathogenic states. Pathogenic potential can be down-regulated in order to maintain commensalism or upregulated in order to harm tissues of the host and obviate or alter immune surveillance negatively66.

The virulence of CA according to the production of several enzymes lipases, phospholipases, esterases and proteases which it used in the cleavage of immune defense proteins, biodegrading of connective tissues and as a result, the pathogen’s acquisition of nutrition, invade and evade of immune defense is aided67,68.

The production of enzymes related to members of multigene families, pH optimum, yeast unique substrate specificity and expression profile. The produced aspartyl protease enzymes have been shown to play several roles. One of them inactivates factor-H and the complement receptors CR3 and CR4 on macrophages, allowing CA to avoid detection by the host’s innate immunity67-70.

In the species CA, virulence is a polygenic trait that includes morphogenetic, genetic, physiological and biochemical characteristics. These characteristics increase the virulence of Candida species, the most important of which are: The transition from yeast to pseudohyphae (in response to specific conditions), phenotypic conversion (to become protected from neutrophil engulfment), biofilm formation (to reluctant against antifungal agents and host immune defense), adherence to host surfaces and metabolic adaptability (stress resistance, cell surface changes and effective utilization of alternative carbon sources). In addition to the production of hydrolytic enzymes (for thecleavage of host immune factors,the degradation of host connective tissues, and the acquisition of nutrients), evade phagocytosis (pyroptosis, phagolysosomal neutralization and host cells lysis by fungal hyphae), combating host nutritional immunity (transporters of micronutrients and proteins that are redundant with alternate cofactors), the production of candidalysin (secretory cytolytic peptide causes harm to host immune system) and evasion from host surface changes immune system (PAMPs masking, changes in cell wall composition and architecture)66. These adaptive characteristics allow CA to thrive in a variety of host niches, overcome host immune defenses and establish itself as a viable pathogen66.

Etiology and condition of oral candidiasis: The mouth cavity, as one of the most important human openings, is exposed to a large number of microbes through food, air and water. Some of them grow, multiply and establish, forming communities within the cavity. The physiochemical environment in the cavity influences both the selection and growth of these microbes67.

The environmental conditions are caused by a variety of molecules produced by the host and resident microbe. Changes in the cavity’s molecular content are likely to alter the community of microbe. As a result, changes in the microbial community inside the oral cavity may occur in the case of various diseased conditions and changed food habits or both. As a result, the presence of certain microbes or an increase in the microbial numbers in a cavity of the mouth may be a good indicator of disease diagnosis68.

Factors that contribute to oral fungal infection are primarily caused by our ignorance of oral health care. Forming of acid in the mouth cavity occurs as a result of both alcohol consumption and smoking, as well as a high intake of carbohydrates and sugar in food. The high rate of alcohol consumption can disrupt the oral microflora and cause the formation of acetaldehyde, which results in mouth fungal colonization48,71,72.

In the same context, epithelial changes, poorly fitting dentures, hormonal disorders, physiological disorders, endocrine disorders, poor oral hygiene, empirical drug therapy and immunologic disorders are some of the other difficult causative factors that cause oral mycosis. The CA is the most common colonizing fungi isolated from the mouth cavity48.

Oral candidiasis especially symptomatic symptoms increases and is affected by numerous conditions and factors. One of the most important factors is the temperature which is the key to many parameters for example ion activity, pH, gas solubility and aggregation of molecules73-76. The mouth temperature varies depending on where you look and this can affect the proportions of bacterial species, the optimum temperature for bacterial growth is 37°C31.

On the other hand, thetongue’supper surface (dorsum), palatal mucosa and buccal mucosa deliver oxygen to aerobic environments which enhance facultative anaerobic growth76. Generally, oral microbes according to aeration separated into anaerobes and aerobes, most of them are either obligate anaerobic or facultatively anaerobic. Facultative anaerobic microorganisms meaning they can grow in the absence or presence of O2 while obligate anaerobic microorganisms meaning they cannot grow in the O2 presence76. Fusobacteria, bacteroides, some actinomycetes and spirochaetes as anaerobic microbes can only reproduce in the reduced buccal areas and they can be found in dental plaque deeper layer and in the gingival crevice77.

Undoubtedly the growth of microbes is affected by the pH of the oral environment, for optimal growth, some microorganisms have preferred neutral pH while others preferred acidic pH, e.g. Actinomyces viscosus and Streptococcus sanguinis (neutral pH), Lactobacillus acidophilus (acidic pH) while Porphyromonas gingivalis (alkaline pH)31,78. The optimum oral pH range is between 7.3 to 6.7 which is adjusted by salivary secretion76. Aframian et al.79 recorded that the mean oral pH value is 6.78. Changes in oral cavity pH are affected by the presence and consumption of food, e.g. usually after consuming sugar, the pH decrease towards acidic under 5.0, while bicarbonate food consumption increase towards alkaline pH 8.0676,78,80. Oral microbes are usually affected by extreme values of alkaline or acid. Plaque microbes are affected by pH fluctuating by sugar daily consumption, but slight pH changes may not affect plaque microbes. Microbial growth nutrients are separated into two kinds, exogenous and endogenous nutrients. Salivary secretions are the main components of endogenous nutrients76,81. The gingival crevice fluid that surrounds the teeth provides albumin as well as other host proteins as endogenous nutrients and its reasons for the variation of oral microbiota75,82. Also during metabolism, carbohydrates biodegrade, acid is produced then the pH degree decrease, which it allows some bacteria to grow at a rapid pace e.g. Streptococcus mutans and lactobacilli while Streptococcus sanguinis decreases31,76.

Diseases and habits that may increase oral candidiasis: Oral candidiasis has three forms angular cheilitis, acute candidiasis and chronic candidiasis48. The CA is one of the commensal microbes in the digestive, genitourinary tracts and mouth. The most common yeast cause oral candidiasis is CA strains, which have fluconazole-resistant between lymphoma and gastrointestinal cancer patients46.

In some immune diseases, an effect on T lymphocytes (CD4 and CD8) make a higher risk of fungal infection in the mouth because it provides primary and secondary immunity48. In the same context, suppressive factors of the immune system by opium addiction exhibit a high risk of mycosis in addicts83. Furthermore, consuming alcohol, smoking, food containing a high level of carbohydrates, immunosuppression, extreme age of the patient and decreasing salivary function are predisposing and colonizing factors for oral mycosis and it has the potential to progress to the chronic stage48. It is not hidden from anyone, smoking and chewing tobacco may cause health hazards involving cancer in mouth tissues. For this reason, oral candidiasis by CA as oral normal flora and opportunistic pathogen in immunocompromised patients especially cancer patients16.

Tobacco plant and health effects: Nicotiana tobacum, a type of tobacco plant, produces tobacco by curing its leaves. Smoking and chewing are two common uses for Nicotiana tobacum. Tobacco includes more than three thousand different compounds, whereas cigarette smoke contains more than four thousand different chemicals, including hazardous substances, of which fifty are particularly cariogenic and cause dental cavities. Nicotine, an alkaloid found in cigarette smoke, makes up about 6-30% of cigarettes. The amount of nicotine in a cigarette ranges from 9 to 30 mg however, the body only absorbs 0.5-2 mg of nicotine each cigarette through respiration84-86.

In tobacco, there are approximately 28 carcinogenic agents16,87. The DNA can be alkylated by tobacco carcinogenic chemicals, which can result in cancer. Chewing and smoking tobacco are linked to a number of health issues in people, including pancreatic, esophageal, mouth and lung cancers. Additionally, it causes teeth to decay and fall out, nicotine addiction, strokes, cardiovascular disorders, an increase in heart rate and nicotine poisoning in youngsters. It also causes digestive issues and a rise in stomach acidity88-90 and early delivery in pregnant women91,92. Catecholamines, free fatty acids and blood pressure can all be raised by nicotine smoking16,93.

It can prevent the production of prostacyclin, which can cause platelets to clump together and cause blood clotting. The amount of nicotine in cured tobacco ranges from 0.2-4.75% by weight, depending on the level of ripeness, plant’s variety, growing environment, leaf position and fertilizer application94,95. The buccal mucosa is able to freely absorb non-ionized nicotine. Nicotine absorption from chewing tobacco is facilitated by buffering it to an alkaline pH. Compared to nicotine found in cigarettes, nicotine found in chewing tobacco is more readily absorbed16,96.

Oral candidiasis is one of the illnesses of the mouth that can be aggravated by a number of risk factors, for instance, the use of exogenous substances like tobacco and cannabis23,97.

The use of cigarettes is a significant risk factor for symptomatic infection in immunocompromised persons, according to epidemiological research. Additionally, smokers were reported to have a greater rate of oral candidal carriage than non-smokers. This could be the reason why 98% of smokers in Indian villages get Candida leukoplakia, which can be treated by quitting the habit18,21,98-101.

Tobacco smoking and oral health: It is said that a person’s oral health is a mirror that reflects their overall health. Erythema, inflammation and edema of the denture-bearing mucosa that may be together with burning or pain are the telltale signs of denture stomatitis102. There are multiple patient factors that affect the onset and severity of denture stomatitis, but still, microbiological factors continue to be one of the most important predisposing factors103. Denture stomatitis’s primary cause is not entirely understood, according to other studies, although various risk factors associated with it have been discovered, such as Candida infection, immune system flaws, mucosal damage, inadequate denture cleanliness and a pattern of wearing dentures83,104.

Basically, buccal Candidal growth is linked to the majority of denture stomatitis cases and vice versa. On the other hand, cigarette smoking is the sole factor or with other factors as a result of oral candidiasis23,50,105. Smoking of tobacco cigarettes was linked to a greater risk of denture stomatitis, with an adjusted odds ratio of 95%. Furthermore, for denture stomatitis, there was a dose-response increase with the highest probability ratio in the fourth quartile92. Tobacco smoking use in other forms, for instance, hookah (nargileh, water pipe, ghalyan, or shisha), has been linked to changes in the component of the microbiome of mouth, the proliferation of Candida spp., as well as immune system cell suppression83,106,107.

Smoking and the presence of oral candidiasis: Galai et al.20 demonstrated that, Candida species were found in 84 % of smokers and 74 % of nonsmokers and also CFU mL–1 averages were reported to increase in smokers more than persons who do not smoke tobacco. Also, Muzurović et al.108 denoted that, smoking influences Candida spp. in oral colonization and both have an adverse effect on dental health. Cigarette smoking and the presence of Candida spp. in the oral cavity both have a negative impact on oral hygiene. Smokers’ microbial colonization was more diverse than that of nonsmokers. Tobacco use influences bacterial acquisition and oral mucosal colonization in favor of periodontal pathogens. Smokers’ microbial colonization was more diverse than that of nonsmokers this achieved by tobacco smoke had a statistically significant effect on smokers’ oral flora. While, in the other study, tobacco consumption did not appear to increment Candida numbers for oral colonization in healthy subjects20,108,109.

Effects of tobacco smoke on oral condition to enhance oropharyngeal candidiasis: Several studies exhibit that, smoking results in a decrease innate immunity by inducing Candidal colonization as well as host infection110. Because of aromatic hydrocarbon compounds found in cigarette tobacco smoke can be transformed by different Candida spp., to carcinogenic compounds, this could imply that CA uses tobacco compounds as nutritional factors111. In the same context, CA may induce the production of N-nitroso(benzyl) methylamine, which contributes to smokers' high Candida leukoplakia levels112.

Cigarette smoking has been linked to localized epithelial changes that allow Candidal colonization25. Tobacco cigarette smoking may provide nutritional support for Candida growth113. This idea has significant implications because the aromatic and heterocyclic hydrocarbon compounds found in the smoke of tobacco cigarettes can be transformed into carcinogenic compounds as an end product by inducible enzyme systems found in Candida species111,112. These theories and ideas provide a partial demonstration of why smokers can be extra vulnerable to candidal leukoplakia, which has a greater risk of malignant transformation than other types of leukoplakia114.

One of the primary virulence factors of CA strains is the ability to change pseudohyphal shape from yeast shape. Many factors can induce this transition e.g. glucose, serum, CO2, proline, N-acetylglucosamine, starvation and temperature (37°C)54-57.

Research in the genus CA approved that this genus has the ability to invade and adhere to the tissues during the development of candidiasis58,59. This adhesion is promoted by yeast cell wall proteins115. Cell wall of Candida contains mannans, glucans, chitins and glycoproteins60-62. The scientists discovered three genes of CA, encoding different chitin synthases (CHS 1 to 3). Any defects in chitin proteins by mutation make mutant yeast cells less virulent than the non-mutant strain studded in an animal model. Overexpression of Sap2, EAP1 and HWP1 genes, which are considered the main virulence factors in CA, increased yeast growth, adhesion and formation of biofilm116,117. Consequently, with a high chitin level, CA can evade the effects of cigarette smoke and the immune system of the host63. In the same context, pretreatment of cigarette smoke condensate CA (CSCCA) was sensitive to oxidative stress while heat or osmotic stress is elevated in resistance. The CA pretreated with cigarette smoke condensation (CSCCA) also had increased chitin content, especially under hyphal culture conditions. During hyphal culture conditions, CA pretreated with cigarette smoke condensate (CSCCA) had a two to eight-fold increase in chitin content116. Smoking causes changes in the conditions of the buccal cavity and raises the likelihood of mucosal infections by oral candidiasis-CA. Cigarette smoke has a significant effect on CA118.

On the other hand, gingival fibroblasts (GF) are important for tissue function and structure. Furthermore, gingival fibroblasts (GF) play an important role in the host immune response against oral candidiasis119,120. In response to stimuli like periodontal pathogenic microbes, GF are activated during the inflammatory process, releasing pro-inflammatory cytokines for instance IL-8, IL-6 and IL-1121,122. The secretion of some inflammatory cytokines modulated by fibroblasts is exposed to tobacco cigarette smoke.

Toxic chemicals derived from smoke have been linked to immune dysfunction. Moreover, pretreatment of cigarette smoke condensate CA (CSCCA) adhere better to the GF, propagated and adapted 3 times the amount than non-treated species. Contact with CA pretreatment of cigarette smoke condensate (CSCCA) affected fibroblasts, causing them to grow at a slower rate and secrete more IL-1. Tobacco smoking may contribute to the pathogenicity of CA, by enhancing the severity of Candidal pathogenicity, fungal virulence and the pathogen’s persistence in cigarette smokers116.

Tobacco users are thus more likely to contract invasive diseases due to several pathogenic bacteria123-125. Tobacco users have also been shown in vitro to induce biofilm formation by a variety of oral/respiratory pathogens, inclusive Streptococcus mutans, Streptococcus pneumoniae, Streptococcus aureus, Pseudomonas aeruginosa, Pseudomonas gingivalis and Klebsiella pneumoniae123-125. Tobacco smoking has also been linked to an increase in CA growth, adhesion and biofilm formation117,126.

In vitro and in vivo studies of tobacco effects on virulence of C. albicans: Avşar et al.16 demonstrate that, prepared methanol and water cold extracts of smoking and chewing tobacco were tested in vitro for their effect on CA morphological changes. These extracts have been shown in studies to enhance switching, hyphal form from yeast form, implying that tobacco may increase the pathogenicity of CA in the human buccal cavity. Tobacco is not only an inducer of the transition process but it considers an excellent medium for this process, this means it may increase the virulence of CA by transitioning to a pathogenic form.

Nicotine is one of the main smoking products, it has a significant impact on the human microflora of the oral cavity, which results in microbiome changes and instability and as well as encourages the unchecked growth of harmful microorganisms. A biofilm is the most frequent type of microbial growth that leads to clinical infection on both hard and soft surfaces. Recent in vitro research recorded the link between tobacco smoking and dental caries, including how nicotine affects the growth of biofilms and the metabolic products of S. mutans and S. sanguinis127-131.

Oral mycosis by Candida species as an etiological agent possesses virulence aspects for instance tooth surfaces adhesion and oral epithelial cells making enhance biofilm formation, swapping phenotypes and morphological transitions, which contribute to the fungal pathogenicity131-135. The onset of oral candidiasis is significantly influenced by the capacity of Candida parapsilosis and CA to cling to both soft and hard oral tissue136.

Some species of Candida especially CA and C. parapsilosis have the ability to phenotypic switching, colonize and production of excess polysaccharide extracellular. These extracellular polysaccharides enhance attachment to human epithelial cells as well as biofilm formation137-139. All of these characteristics make Candida an etiological agent of nosocomial infection, the 4th most common infection140. Yeast adhesion processes to endothelial and epithelial human cells are controlled by Candidal agglutinin like sequences genes 1, 3 and 5 (CALS 1, 3, 5) which produced specialized proteins that enhance initiation, colonization and dental plaque development processes, in addition to Candidal adhesion like hyphae wall protein gene 1 (CALHWP1) make cell surface hydrophobic141-143. Researchers notice that the main component of nicotine enhances extracellular polysaccharides production as well as Candidal colonization. One to two mg per milliliter encourages Candidal biofilm formation. Furthermore, CALHWP1 and CALS 3 expression elevated when nicotine concentration was elevated. Nicotine significantly altered the composition and proportion of yeast cells, as well as the extracellular polysaccharide amounts which increase biofilm matrix and thickness which could promote oral candidiasis, especially CA as well as C. parapsilosis species144. Moreover, several results explain candidiasis and tobacco smoking, such as smoking was significantly associated with Candida pathogenicity in patients with clinically suspected oral leukoplakia and smoking worsens oral candidiasis and dampens epithelial cell defense response studied in experimental animals145,146.

Over seven thousand identified molecules in tobacco cigarette smoke, these molecules may be free radicals and/or oxidants147. It has the potential to alter the oral condition and cause severe oxidative stress, thereby damaging the epithelial barrier of the mouth148.

These oxidative molecules during smoking activate epithelial cells proteins called oxidative stress sensing proteins, especially nuclear factor erythrocyte 2-related factor 2 (NFERF2)149. The induction of NFERF2 is widely thought to have anti-inflammatory properties. Also, NFERF2 is transported into the cell nucleus in the existence of additional electrophilic chemicals to activate antioxidant enzyme genes expression, for instance, haem-oxygenase-1 and NAD(P)H dehydrogenase quinone-1150,151. Furthermore, NFERF2 inhibits the secretion of pro-inflammatory cytokines such as interleukin IL-1β and (IL)-6 in response to lipopolysaccharide152. The NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome recognizes several pathogens and is critical in the fight against CA infection153.

In the oral mucosa, smoking caused redox dysfunction and oxidative stress. The NLRP3 inflammasome was negatively regulated by smoking-induced NFERF2, which impaired the oral mucosal defense response and exceed susceptibility to CA. The NFERF2 pathway may be engaged in the pathogenicity of mouth by mediating an antioxidative response to cigarette smoke exposure and suppressing human immunity against CA. The NFERF2's negative regulatory effect on NLRP3 is involved in smoking-induced oral mucosa immunosuppression, increasing susceptibility to CA. The NFERF2, which has been linked to inflammation and oxidative stress, is thought to be a possible therapeutic objective and a crucial regulator for smoking-related oral diseases and mouth candidiasis for instance leucoplakia154.

Smoking causes disruptions in the buccal cavity and increases the risk of mucosal infections caused by CA118. Nicotine influenced CA pathogenic characteristics such as morphology, biofilm formation and hyphal growth, as well as virulence-related gene expressions, which were found to be differentially expressed according to cigarette nicotine concentration. Pure nicotine at MIC (4 mg mL–1) inhibited CA growth, while 0.1 mg mL–1 enhanced biofilm formation. Cigarette smoke condensate, on the other hand, has no effect on CA biofilm formation at this nicotine below MIC concentration which it recorded at 0.10 mg per milliliter in the same study. Furthermore, both pure nicotine and cigarette smoke condensate increased the expression of the genes secreted aspartyl proteinase 2 as well as hyphal wall protein 1. Pure nicotine has a different effect on the formation of CA biofilms. An in vitro study found that antifungal treatments (below MICs) against CA reduce nicotine’s effect on the expression of virulence-related gene. However, there is a chance that smoking will interfere with various concentrations of antifungal (amphotericin and fluconazole) treatments118.

CONCLUSION


Numerous articles have studied the link between smoking and oral Candida carriage, but it is important to understand the relationship’s fundamental mechanisms clearly from different sides especially when few researchers question the negative impact of smoking. This review has emphasized how smoking cigarettes affects the expression of genes related to virulence, the change from yeast to hyphal form and other pathogenic characteristics of Candida. Smoking tobacco is not only thought to speed up the transition process, but it is also a great medium for it. Smoking has the potential to worsen oral health conditions and increase oxidative stress, which can harm the mouth’s epithelial barrier, prevent the release of pro-inflammatory cytokines and make Candida more pathogenic in people with clinically suspected oral leukoplakia. Moreover, smoking increased the oral mucosa susceptibility to Candida, suppressed host immunity against Candida and caused oxidative stress, redox dysfunction and oral mucosal defense response impairment. Furthermore, nicotine affects thickens and increases the biofilm matrix, which may encourage oral candidiasis. Thus, beyond any doubt that smoking cigarettes harm oral health, which harms overall health as a result.

SIGNIFICANCE STATEMENT


The effect of smoking on Candida as one of the most important opportunistic organisms and evidence of the balance of the oral microbiota. This study introduces a complete view of the relationship between tobacco smoking and oral candidiasis and explains how tobacco smoking enhances oral candidiasis by promoting Candidal pathogenic characteristics. This study will help the researcher to uncover the role of tobacco smoking in Candidal vorticity and pathogenicity in addition to the understanding negative impact on the oral cavity and immune response of the host.

ACKNOWLEDGMENT


This publication was supported by the Deanship of Scientific Research at Prince Sattam bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.

REFERENCES


  1. Tazi, N., X. Pigeon, J.M. Mbuyi-Boisvert, S. Giret, F. Béland and M. Rouabhia, 2021. Effect of cannabis smoke condensate on C. albicans growth and biofilm formation. Microorganisms, Vol. 9.
    CrossRefDirect Link

  2. Xu, H. and A. Dongari-Bagtzoglou, 2015. Shaping the oral mycobiota: Interactions of opportunistic fungi with oral bacteria and the host. Curr. Opin. Microbiol., 26: 65-70.
    CrossRefDirect Link

  3. Gao, L., T. Xu, G. Huang, S. Jiang, Y. Gu and F. Chen, 2018. Oral microbiomes: More and more importance in oral cavity and whole body. Protein Cell, 9: 488-500.
    CrossRefDirect Link

  4. Verma, D., P.K. Garg and A.K. Dubey, 2018. Insights into the human oral microbiome. Arch. Microbiol., 200: 525-540.
    CrossRefDirect Link

  5. Zhang, Y., X.Wang, H. Li, C. Ni, Z. Du and F. Yan, 2018. Human oral microbiota and its modulation for oral health. Biomed. Pharmacother., 99: 883-893.
    CrossRefDirect Link

  6. Wade, W.G., 2013. The oral microbiome in health and disease. Pharmacol. Res., 69: 137-143.
    CrossRefDirect Link

  7. Marsh, P.D. and E. Zaura, 2017. Dental biofilm: Ecological interactions in health and disease. J. Clin. Periodontology, 44: S12-S22.
    CrossRefDirect Link

  8. Baumgardner, D.J., 2019. Oral fungal microbiota: To thrush and beyond. J. Patient Centered Res. Rev., 6: 252-261.
    CrossRefDirect Link

  9. Shirtliff, M.E., B.M. Peters and M.A. Jabra-Rizk, 2009. Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol. Lett., 299: 1-8.
    CrossRefDirect Link

  10. Chevalier, M., S. Ranque and I. Prêcheur, 2018. Oral fungal-bacterial biofilm models in vitro: A review. Med. Mycol. 56: 653-667.
    CrossRefDirect Link

  11. Lu, M., S. Xuan and Z. Wang, 2019. Oral microbiota: A new view of body health. Food Sci. Hum. Wellness, 8: 8-15.
    CrossRefDirect Link

  12. Peng, X., L. Cheng, Y. You, C. Tang and B. Ren et al., 2022. Oral microbiota in human systematic diseases. Int. J. Oral Sci., Vol. 14.
    CrossRefDirect Link

  13. Raju, S.B. and S. Rajappa, 2011. Isolation and identification of Candida from the oral cavity. Int. Scholarly Res. Not., Vol. 2011.
    CrossRefDirect Link

  14. Molero, G., R. Diez-Orejas, F. Navarro-Garcia, L. Monteoliva and J. Pla et al., 1998. Candida albicans: Genetics, dimorphism and pathogenicity. Int. Microbiol., 1: 95-106.
    Direct Link

  15. Ali, A. and S.M. Karuppayil, 2018. Tobacco extract induces yeast to hyphal form transition in the human pathogen, Candida albicans. Am. J. Clin. Microbiol. Antimicrob., Vol. 1.
    Direct Link

  16. Avşar, A., Ö. Darka, B. Topaloğlu and Y. Bek, 2008. Association of passive smoking with caries and related salivary biomarkers in young children. Arch. Oral Biol., 53: 969-974.
    CrossRefDirect Link

  17. Oliver, D.E. and E.J. Shillitoe, 1984. Effects of smoking on the prevalence and intraoral distribution of Candida albicans. J. Oral Pathol. Med., 13: 265-270.
    CrossRefDirect Link

  18. Kadir, T., R. Pisiriciler, S. Akyüz, A. Yarat, N. Emekli and A. Ipbüker, 2002. Mycological and cytological examination of oral candidal carriage in diabetic patients and non-diabetic control subjects: Thorough analysis of local aetiologic and systemic factors. J. Oral Rehabil., 29: 452-457.
    CrossRefDirect Link

  19. Al-Dwairi, Z.N., A.M.G. Darwazeh and A.A.W. Al-Zwairi, 2010. The relationship between tobacco smoking and oral colonization with candida species. J. Contemp. Dent. Pract., 11: 17-24.
    CrossRefDirect Link

  20. Galai, N., L.P. Park, J. Wesch, B. Visscher, S. Riddler and J.B. Margolick, 1997. Effect of smoking on the clinical progression of HIV-1 infection. J. Acquired Immune Deficiency Syndromes Hum. Retrovirology, 14: 451-458.
    CrossRefDirect Link

  21. Li, H., M.X. Miao, C.L. Jia, Y.B. Cao, T.H. Yan, Y.Y. Jiang and F. Yang, 2022. Interactions between Candida albicans and the resident microbiota. Front. Microbiol., Vol. 13.
    CrossRefDirect Link

  22. Soysa, N.S. and A.N.B. Ellepola, 2005. The impact of cigarette/tobacco smoking on oral candidosis: An overview. Oral Dis., 11: 268-273.
    CrossRefDirect Link

  23. Kilian, M., 2018. The oral microbiome-friend or foe? Eur. J. Oral Sci., 126: 5-12.
    CrossRefDirect Link

  24. Schroeder, B.O. and F. Bäckhed, 2016. Signals from the gut microbiota to distant organs in physiology and disease. Nat. Med., 22: 1079-1089.
    CrossRefDirect Link

  25. Butler, R.R., J.T.A. Soomer-James, M. Frenette and J.F. Pombert, 2017. Complete genome sequences of two human oral microbiome commensals: Streptococcus salivarius ATCC 25975 and S. salivarius ATCC 27945. Genome Announce., Vol. 5.
    CrossRefDirect Link

  26. Marsh, P.D., T. Do, D. Beighton and D.A. Devine, 2016. Influence of saliva on the oral microbiota. Periodontology, 70: 80-92.
    CrossRefDirect Link

  27. Segata, N., S.K. Haake, P. Mannon, K.P. Lemon and L. Waldron et al., 2012. Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol., Vol. 13.
    CrossRefDirect Link

  28. Welch, J.L.M., B.J. Rossetti, C.W. Rieken, F.E. Dewhirst and G.G. Borisy, 2016. Biogeography of a human oral microbiome at the micron scale. Proc. Natl. Acad. Sci., 113: E791-E800.
    CrossRefDirect Link

  29. Willett, N.and R. White, 1991. Essential Dental Microbiology. 2nd Edn., Appleton & Lange, UK, pp: 307.
    Direct Link

  30. Marsh, P.D., 2004. Dental plaque as a microbial biofilm. Caries Res., 38: 204-211.
    CrossRefDirect Link

  31. Abranches, J., L. Zeng, J.K. Kajfasz, S.R. Palmer and B. Chakraborty et al., 2018. Biology of oral streptococci. Microbiol. Spectr., Vol. 6.
    CrossRefDirect Link

  32. Grusell, E.N., G. Dahlén, M. Ruth, L. Ny, M. Quiding-Järbrink, H. Bergquist and M. Bove, 2013. Bacterial flora of the human oral cavity, and the upper and lower esophagus. Dis. Esophagus, 26: 84-90.
    CrossRefDirect Link

  33. Dzidic, M., M.C. Collado, T. Abrahamsson, A. Artacho, M. Stensson, M.C. Jenmalm and A. Mira, 2018. Oral microbiome development during childhood: An ecological succession influenced by postnatal factors and associated with tooth decay. ISME J., 12: 2292-2306.
    CrossRefDirect Link

  34. Gomez, A., J.L. Espinoza, D.M. Harkins, P. Leong and R. Saffery et al., 2017. Host genetic control of the oral microbiome in health and disease. Cell Host Microbe, 22: 269-278.
    CrossRefDirect Link

  35. Hujoel, P.P., M.L.A. Hujoel and G.A. Kotsakis, 2018. Personal oral hygiene and dental caries: A systematic review of randomised controlled trials. Gerodontology, 35: 282-289.
    CrossRefPubMedDirect Link

  36. Tanner A.C., C.A. Kressirer and L.L. Faller, 2016. Understanding caries from the oral microbiome perspective. J. Calif. Dent. Assoc., 44: 437-446.
    Direct Link

  37. Wang, J., Y. Gao and F. Zhao, 2016. Phage-bacteria interaction network in human oral microbiome. Environ. Microbiol., 18: 2143-2158.
    CrossRefDirect Link

  38. Dudek, N.K., C.L. Sun, D. Burstein, R.S. Kantor and D.S.A. Goltsman et al., 2017. Novel microbial diversity and functional potential in the marine mammal oral microbiome. Curr. Biol., 27: 3752-3762.e6.
    CrossRefDirect Link

  39. Presti, R.M., S.A. Handley, L. Droit, M. Ghannoum and M. Jacobson et al., 2018. Alterations in the oral microbiome in HIV-infected participants after antiretroviral therapy administration are influenced by immune status. AIDS, 32: 1279-1287.
    CrossRefDirect Link

  40. Sällberg, M., 2009. Oral viral infections of children. Periodontology, 49: 87-95.
    CrossRefDirect Link

  41. Baker, J.L., B. Bor, M. Agnello, W. Shi and X. He, 2017. Ecology of the oral microbiome: Beyond bacteria. Trends Microbiol., 25: 362-374.
    CrossRefDirect Link

  42. Wang, X., L. Du, J. You, J.B. King and R.H. Cichewicz, 2011. Fungal biofilm inhibitors from a human oral microbiome-derived bacterium. Org. Biomol. Chem., 10: 2044-2050.
    CrossRefDirect Link

  43. Alrayyes, S.F., H.M. Alruwaili, I.A. Taher, K.M. Elrahawy, A.H. Almaeen, A.O. Ashekhi and M.K. Alam, 2019. Oral Candidal carriage and associated risk indicators among adults in Sakaka, Saudi Arabia. BMC Oral Health, Vol. 19.
    CrossRefDirect Link

  44. Damasceno, J.L., R.A. dos Santos, A.H. Barbosa, L.A. Casemiro, R.H. Pires and C.H.G. Martins, 2017. Risk of fungal infection to dental patients. Sci. World J., Vol. 2017.
    CrossRefDirect Link

  45. Maheronnaghsh, M., S. Tolouei, P. Dehghan, M. Chadeganipour and M. Yazdi, 2016. Identification of Candida species in patients with oral lesion undergoing chemotherapy along with minimum inhibitory concentration to fluconazole. Adv. Biomed. Res., Vol. 5.
    CrossRefDirect Link

  46. Aggarwal, N., S. Bhateja, G. Arora and T. Yasmin, 2018. Candidiasis-The most common fungal infection of the oral cavity. Biomed. J. Sci. Technol. Res., 8: 6487-6491.
    CrossRefDirect Link

  47. Lenka, S., S.K. Swain, R. Bhuyan and M.C. Sahu, 2020. Fungal infection in the oral cavity: A review. Int. J. Curr. Res. Rev., 12: 149-153.
    CrossRefDirect Link

  48. Coronado-Castellote, L. and Y. Jimenez-Soriano, 2013. Clinical and microbiological diagnosis of oral candidiasis. J. Clin. Exp. Dent., 5: e279-e286.
    CrossRefDirect Link

  49. Vila, T., A.S. Sultan, D. Montelongo-Jauregui and M.A. Jabra-Rizk, 2020. Oral candidiasis: A disease of opportunity. J. Fungi, Vol. 6.
    CrossRefDirect Link

  50. Odds, F.C., 2009. Molecular phylogenetics and epidemiology of Candida albicans. Future Microbiol., 5: 67-79.
    CrossRefDirect Link

  51. Richardson, M. and C. Lass-Flörl, 2008. Changing epidemiology of systemic fungal infections. Clin. Microbiol. Infect., 14: 5-24.
    CrossRefDirect Link

  52. Peña, D.E.R., L.M.A.R. Innocentini, M.C.P. Saraiva, A.G. Lourenço and A.C.F. Motta, 2021. Oral candidiasis prevalence in human immunodeficiency virus-1 and pulmonary tuberculosis coinfection: A systematic review and meta-analysis. Microb. Pathogen., Vol. 150.
    CrossRefDirect Link

  53. Shepherd, M.G., 1991. Morphogenesis in Candida albicans. In: Candida Albicans Cellular and Molecular Biology, Prasad, R., (Ed.). Springer, Germany, Berlin, Heidelberg, ISBN: 978-3-642-75255-1, pp: 5-19.
    CrossRefDirect Link

  54. Ernst, J.F., 2000. Transcription factors in Candida albicans-environmental control of morphogenesis. Microbiology, 146: 1763-1774.
    CrossRefDirect Link

  55. Hudson, D.A., Q.L. Sciascia, R.J. Sanders, G.E. Norris, P.J.B. Edwards, P.A. Sullivan and P.C. Farley, 2004. Identification of the dialysable serum inducer of germ-tube formation in Candida albicans. Microbiology, 150: 3041-3049.
    CrossRefDirect Link

  56. Biswas, S., P.V. Dijck and A. Datta, 2007. Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol. Mol. Biol. Rev., 71: 348-376.
    CrossRefDirect Link

  57. Park, H., Y. Liu, N. Solis, J. Spotkov and J. Hamaker, 2009. Transcriptional responses of Candida albicans to epithelial and endothelial cells. Eukaryotic Cell, 8: 1498-1510.
    CrossRefDirect Link

  58. Zakikhany, K., J.R. Naglik, A. Schmidt-Westhausen, G. Holland, M. Schaller and B. Hube, 2007. In vivo transcript profiling of Candida albicans identifies a gene essential for interepithelial dissemination. Cell. Microbiol., 9: 2938-2954.
    CrossRefDirect Link

  59. Free, S.J., 2013. Fungal Cell Wall Organization and Biosynthesis. In: Advances in Genetics, Friedmann, T., J.C. Dunlap and S.F. Goodwin (Eds.), Elsevier Inc., Netherlands, ISBN: 978-0-12-407677-8, pp: 33-82.
    CrossRefDirect Link

  60. Roncero, C., 2002. The genetic complexity of chitin synthesis in fungi. Curr. Genet., 41: 367-378.
    CrossRefDirect Link

  61. Ruiz-Herrera, J., J.M. González-Prieto and R. Ruiz-Medrano, 2002. Evolution and phylogenetic relationships of chitin synthases from yeasts and fungi. FEMS Yeast Res., 1: 247-256.
    CrossRefDirect Link

  62. Gow, N.A., P.W. Robbins, J.W. Lester, A.J. Brown, W.A. Fonzi, T. Chapman and O.S. Kinsman, 1994. A hyphal-specific chitin synthase gene (CHS2) is not essential for growth, dimorphism, or virulence of Candida albicans. Proc. Natl. Acad. Sci., 91: 6216-6220.
    CrossRefDirect Link

  63. Ruiz-Herrera, J., M.V. Elorza, E. Valentín and R. Sentandreu, 2006. Molecular organization of the cell wall of Candida albicans and its relation to pathogenicity. FEMS Yeast Res., 6: 14-29.
    CrossRefDirect Link

  64. Mio, T., T. Yabe, M. Sudoh, Y. Satoh, T. Nakajima, M. Arisawa and H. Yamada-Okabe, 1996. Role of three chitin synthase genes in the growth of Candida albicans. J. Bacteriol., 178: 2416-2419.
    CrossRefDirect Link

  65. da Silva Dantas, A., K.K. Lee, I. Raziunaite, K. Schaefer, J. Wagener, B. Yadav and N.A.R. Gow, 2016. Cell biology of Candida albicans–host interactions. Curr. Opin. Microbiol., 34: 111-118.
    CrossRefDirect Link

  66. Schaller, M., C. Borelli, H.C. Korting and B. Hube, 2005. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses, 48: 365-377.
    CrossRefDirect Link

  67. Gropp, K., L. Schild, S. Schindler, B. Hube, P.F. Zipfel and C. Skerka, 2009. The yeast Candida albicans evades human complement attack by secretion of aspartic proteases. Mol. Immunol., 47: 465-475.
    CrossRefDirect Link

  68. Hube, B., M. Monod, D.A. Schofield, A.J.P. Brown and N.A.R. Gow, 1994. Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol. Microbiol., 14: 87-99.
    CrossRefDirect Link

  69. Svoboda, E., A.E. Schneider, N. Sándor, U. Lermann and P. Staib et al., 2015. Secreted aspartic protease 2 of Candida albicans inactivates factor H and the macrophage factor H-receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18). Immunol. Lett., 168: 13-21.
    CrossRefDirect Link

  70. Sarmah, R., R.A. Khan and K.R. Devi, 2021. Microbes in human oral cavity: A review. Rev. Res. Med. Microbiol., 32: 75-82.
    CrossRefDirect Link

  71. Homann, N., J. Tillonen, J.H. Meurman, H. Rintamaki and C. Lindqvist et al., 2000. Increased salivary acetaldehyde levels in heavy drinkers and smokers: A microbiological approach to oral cavity cancer. Carcinogenesis, 21: 663-668.
    CrossRefDirect Link

  72. Charyulu, R.N., B.S. Shripriya, J. Jose and A.V. Shetty, 2013. Design and characterization of mucoadhesive buccal patch containing antifungal agent for oral candidiasis. Int. J. Pharm. Phytopharmacological Res., 3: 245-249.
    Direct Link

  73. Knight, L. and J. Fletcher, 1971. Growth of Candida albicans in saliva: Stimulation by glucose associated with antibiotics, corticosteroids, and diabetes mellitus. J. Infect. Dis., 123: 371-377.
    CrossRefDirect Link

  74. Sbordone, L. and C. Bortolaia, 2003. Oral microbial biofilms and plaque-related diseases: Microbial communities and their role in the shift from oral health to disease. Clin. Oral Invest., 7: 181-188.
    CrossRefDirect Link

  75. Marcotte, H. and M.C. Lavoie, 1998. Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol. Mol. Biol. Rev., 62: 71-109.
    CrossRefDirect Link

  76. MacFarlane, T.W. and L.P. Samaranayake, 1989. Introduction. In: Clinical Oral Microbiology, MacFarlane, T.W. and L.P. Samaranayake, (Eds.), Elsevier, US, ISBN: 978-0-7236-0934-6, pp: 1-3.
    CrossRefDirect Link

  77. Marsh, P.D., 2000. Role of the oral microflora in health. Microb. Ecol. Health Dis., 12: 130-137.
    CrossRefDirect Link

  78. Aframian, D.J., T. Davidowitz and R. Benoliel, 2006. The distribution of oral mucosal pH values in healthy saliva secretors. Oral Dis., 12: 420-423.
    CrossRefDirect Link

  79. Anderson, L.A. and R. Orchardson, 2003. The effect of chewing bicarbonate-containing gum on salivary flow rate and pH in humans. Arch. Oral. Biol., 48: 201-204.
    CrossRefDirect Link

  80. Samaranayake, L.P., 2018. Essential Microbiology for Dentistry. 5th Edn., Elsevier, US, Pages: 400.
    Direct Link

  81. Bowden, G.H.W. and Y.H. Li, 1997. Nutritional influences on biofilm development. Adv. Dent. Res., 11: 81-99.
    CrossRefDirect Link

  82. Sardari, F., P. Khalili, H. Hakimi, S. Mahmoudaghaei and P. Abedi, 2021. The prevalence of denture stomatitis in cigarette and hookah smokers and opium addicts: Findings from Rafsanjan Cohort study. BMC Oral Health, Vol. 21.
    CrossRefDirect Link

  83. Hoffmann, D. and M.V. Djordjevic, 1997. Chemical composition and carcinogenicity of smokeless tobacco. Adv. Dent. Res., 11: 322-329.
    CrossRefDirect Link

  84. Hoffmann, D., I. Hoffmann and K. El-Bayoumy, 2001. The less harmful cigarette: A controversial issue. A tribute to Ernst L. Wynder. Chem. Res. Toxicol., 14: 767-790.
    CrossRefPubMedDirect Link

  85. Gellner, C.A., D.D. Reynaga and F.M. Leslie, 2016. Cigarette smoke extract: A preclinical model of tobacco dependence. Curr. Protoc. Neurosci., Vol. 77.
    CrossRefDirect Link

  86. Foulds, J., L. Ramstrom, M. Burke and K. Fagerström, 2003. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tobacco Control, 12: 349-359.
    CrossRefDirect Link

  87. IARC, 2007. Smokeless Tobacco and Some Tobacco-Specific N-Nitrosamines. Vol. 89, IARC Publication, France, ISBN-13: 978-92-832-1589-9, Pages: 626.
    Direct Link

  88. Piano, M.R., N.L. Benowitz, G.A. FitzGerald, S. Corbridge and J. Heath et al., 2010. Impact of smokeless tobacco products on cardiovascular disease: Implications for policy, prevention, and treatment. Circulation, 122: 1520-1544.
    CrossRefDirect Link

  89. Connolly, G.N., P. Richter, A. Aleguas, T.F. Pechacek, S.B. Stanfill and H.R. Alpert, 2010. Unintentional child poisonings through ingestion of conventional and novel tobacco products. Pediatrics, 125: 896-899.
    CrossRefDirect Link

  90. Srinivasa, C.R. and S.Y. Emmanuel, 2013. The effect of chronic tobacco smoking and chewing on the lipid profile. J. Clin. Diagn. Res., 7: 31-34.
    CrossRefPubMedDirect Link

  91. Cohen, G., J.C. Roux, R. Grailhe, G. Malcolm, J.P. Changeux and H. Lagercrantz, 2005. Perinatal exposure to nicotine causes deficits associated with a loss of nicotinic receptor function. Proc. Natl. Acad. Sci., 102: 3817-3821.
    CrossRefDirect Link

  92. Baba, S., A.K. Wikström, O. Stephansson and S. Cnattingius, 2014. Influence of snuff and smoking habits in early pregnancy on risks for stillbirth and early neonatal mortality. Nicotine Tob. Res., 16: 78-83.
    CrossRefDirect Link

  93. Brischetto, C.S., W.E. Connor, S.L. Connor and J.D. Matarazzo, 1983. Plasma lipid and lipoprotein profiles of cigarette smokers from randomly selected families: Enhancement of hyperlipidemia and depression of high-density lipoprotein. Am. J. Cardiol., 52: 675-680.
    CrossRefDirect Link

  94. Tso, T.C., 1990. Production, Physiology, and Biochemistry of Tobacco Plant. 1st Edn., IDEALS, Beltsville, Singapore, Pages: 753.
    Direct Link

  95. Stratton, K., P. Shetty, R. Wallace and S. Bondurant, 2001. Clearing the smoke: The science base for tobacco harm reduction. Tob. Control, 10: 189-195.
    CrossRefDirect Link

  96. Benowitz, N.L., 1988. Nicotine and smokeless tobacco. Cancer J. Clin., 38: 244-247.
    CrossRefDirect Link

  97. de Almeida, O.P. and C. Scully, 2002. Fungal infections of the mouth. Braz. J. Oral Sci., 1: 19-26.
    CrossRefDirect Link

  98. Daftary, D.K., F.S. Mehta, P.C. Gupta and J.J. Pindborg, 1972. The presence of Candida in 723 oral leukoplakias among Indian villagers. Eur. J. Oral Sci., 80: 75-79.
    CrossRefDirect Link

  99. Willis, A.M., W.A. Coulter, C.R. Fulton, J.R. Hayes, P.M. Bell and P.J. Lamey, 1999. Oral candidal carriage and infection in insulin-treated diabetic patients. Diabetic Med., 16: 675-679.
    CrossRefPubMedDirect Link

  100. Greenspan, D., E. Komaroff, M. Redford, J.A. Phelan and M. Navazesh et al., 2000. Oral mucosal lesions and HIV viral load in the womens interagency HIV study (WIHS). J. Acquired Immune Deficiency Syndromes, 25: 44-50.
    CrossRefDirect Link

  101. Johnson, N.W. and C.A. Bain, 2000. Tobacco and oral disease. Br. Dent. J., 189: 200-206.
    CrossRefDirect Link

  102. Hilgert, J.B., J.M. do Amaral Giordani, R.F. de Souza, E.M. Da Ros Wendland, O.P. D'Avila and F.N. Hugo, 2016. Interventions for the management of denture stomatitis: A systematic review and meta-analysis. J. Am. Geriatrics Soc., 64: 2539-2545.
    CrossRefDirect Link

  103. Hannah, V.E., L. O'Donnell, D. Robertson and G. Ramage, 2017. Denture stomatitis: Causes, cures and prevention. Primary Dent. J., 6: 46-51.
    CrossRefDirect Link

  104. Gendreau, L. and Z.G. Loewy, 2011. Epidemiology and etiology of denture stomatitis. J. Prosthodontics, 20: 251-260.
    CrossRefDirect Link

  105. Alzayer, Y.M., G.F. Gomez, G.J. Eckert, J.A. Levon and R.L. Gregory, 2020. The impact of nicotine and cigarette smoke condensate on metabolic activity and biofilm formation of Candida albicans on acrylic denture material. J. Prosthodontics, 29: 173-178.
    CrossRefDirect Link

  106. Shakhatreh, M.A.K., O.F. Khabour, K.H. Alzoubi, M.M. Masadeh, E.I. Hussein and G.N. Bshara, 2018. Alterations in oral microbial flora induced by waterpipe tobacco smoking. Int. J. Gen. Med., 11: 47-54.
    CrossRefDirect Link

  107. Mokeem, S.A., T. Abduljabbar, A.A. Al‐Kheraif, M.N. Alasqah, D. Michelogiannakis, L.P. Samaranayake and F. Javed, 2019. Oral Candida carriage among cigarette‐ and waterpipe‐smokers, and electronic cigarette users. Oral Dis., 25: 319-326.
    CrossRefDirect Link

  108. Muzurović, S., M. Hukić, E. Babajić and R. Smajić, 2013. The relationship between cigarette smoking and oral colonization with Candida species in healthy adult subjects. [Bosnian] Medicinski Glasnik, 10: 397-399.
    Direct Link

  109. Ogba, O.M., J.J. Ewa, O.A. Olorode and M. Mbah, 2017. Effect of tobacco smoking on oral microbial flora and the relationship with oral health in Calabar, Nigeria. Int. J. Biol. Lab. Sci., 6: 1-5.
    Direct Link

  110. Ortega, E., C. Barriga and A.B. Rodríguez, 1994. Decline in the phagocytic function of alveolar macrophages from mice exposed to cigarette smoke. Comp. Immunol. Microbiol. Infect. Dis., 17: 77-84.
    CrossRefDirect Link

  111. Hsia, C.C., T.T. Sun, Y.Y. Wang, L.M. Anderson, D. Armstrong and R.A. Good, 1981. Enhancement of formation of the esophageal carcinogen benzylmethylnitrosamine from its precursors by Candida albicans. Proc. Natl. Acad. Sci., 78: 1878-1881.
    CrossRefDirect Link

  112. Krogh, P., B. Hald and P. Holmstrup, 1987. Possible mycological etiology of oral mucosal cancer: Catalytic potential of infecting Candida aibicans and other yeasts in production of N-nitrosobenzylmethylamine. Carcinogenesis, 8: 1543-1548.
    CrossRefDirect Link

  113. Käppeli, O., 1986. Cytochromes P-450 of yeasts. Microbiol. Rev., 50: 244-258.
    CrossRefDirect Link

  114. Chiu, C.T., C.F. Li, J.R. Li, J. Wang and C.Y. Chuang et al., 2010. Candida invasion and influences in smoking patients with multiple oral leucoplakias-A retrospective study. Mycoses, 54: e377-e383.
    CrossRefDirect Link

  115. Plaine, A., L. Walker, G. da Costa, H.M. Mora-Montes and A. McKinnon et al., 2008. Functional analysis of Candida albicans GPI-anchored proteins: Roles in cell wall integrity and caspofungin sensitivity. Fungal Genet. Biol., 45: 1404-1414.
    CrossRefDirect Link

  116. Alanazi, H., A. Semlali, L. Perraud, W. Chmielewski, A. Zakrzewski and M. Rouabhia, 2014. Cigarette smoke-exposed Candida albicans increased chitin production and modulated human fibroblast cell responses. BioMed. Res. Int., Vol. 2014.
    CrossRefDirect Link

  117. Semlali, A., K. Killer, H. Alanazi, W. Chmielewski and M. Rouabhia, 2014. Cigarette smoke condensate increases C. albicans adhesion, growth, biofilm formation, and EAP1, HWP1 and SAP2 gene expression. BMC Microbiol., Vol. 14.
    CrossRefDirect Link

  118. Haghighi, F., L. Andriasian, N.C. Tran and R. Lux, 2022. Effect of cigarette and e-cigarette smoke condensates on Candida albicans biofilm formation and gene expression. Int. J. Environ. Res. Public Health, Vol. 19.
    CrossRefDirect Link

  119. Bromuro, C., A. Torosantucci, M.J. Gomez, F. Urbani and A. Cassone, 1994. Differential release of an immunodominant 65 kDa mannoprotein antigen from yeast and mycelial forms of Candida albicans. J. Med. Vet. Mycol., 32: 447-459.
    CrossRefDirect Link

  120. Rouabhia, M., M. Schaller, C. Corbucci, A. Vecchiarelli, S.K.H. Prill, L. Giasson and J.F. Ernst, 2005. Virulence of the fungal pathogen Candida albicans requires the five isoforms of protein mannosyltransferases. Infect. Immun., 73: 4571-4580.
    CrossRefDirect Link

  121. Bartold, P.M. and D.R. Haynes, 1991. Interleukin-6 production by human gingival fibroblasts. J. Periodontal Res., 26: 339-345.
    CrossRefPubMedDirect Link

  122. Sismey-Durrant, H.J. and R.M. Hopps, 1991. Effect of lipopolysaccharide from Porphyromonas gingivalis on prostaglandin E2 and interleukin-1β release from rat periosteal and human gingival fibroblasts in vitro. Oral Microbiol. Immunol., 6: 378-380.
    CrossRefDirect Link

  123. Li, Y.H., P.C.Y. Lau, N. Tang, G. Svensäter, R.P. Ellen and D.G. Cvitkovitch, 2002. Novel two-component regulatory system involved in biofilm formation and acid resistance in Streptococcus mutans. J. Bacteriol., 184: 6333-6342.
    CrossRefDirect Link

  124. Bagaitkar, J., D.R. Demuth, C.A. Daep, D.E. Renaud, D.L. Pierce and D.A. Scott, 2010. Tobacco upregulates P. gingivalis fimbrial proteins which induce TLR2 hyposensitivity. PLoS ONE, Vol 5.
    CrossRefDirect Link

  125. Mutepe, N.D., R. Cockeran, H.C. Steel, A.J. Theron, T.J. Mitchell, C. Feldman and R. Anderson, 2013. Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin. Eur. Respir. J., 41: 392-395.
    CrossRefDirect Link

  126. Baboni, F.B., D. Barp, A.C.S. de Azevedo Izidoro, L.P. Samaranayake and E.A.R. Rosa, 2009. Enhancement of Candida albicans virulence after exposition to cigarette mainstream smoke. Mycopathologia, Vol. 168.
    CrossRefDirect Link

  127. Yoshida, A. and H.K. Kuramitsu, 2002. Multiple Streptococcus mutans genes are involved in biofilm formation. Appl. Environ. Microbiol., 68: 6283-6291.
    CrossRefDirect Link

  128. Ge, Y., P.W. Caufield, G.S. Fisch and Y. Li, 2008. Streptococcus mutans and Streptococcus sanguinis colonization correlated with caries experience in children. Caries Res., 42: 444-448.
    CrossRefDirect Link

  129. Wen, Z.T., D. Yates, S.J. Ahn and R.A. Burne, 2010. Biofilm formation and virulence expression by Streptococcus mutans are altered when grown in dual-species model. BMC Microbiol., Vol. 11.
    CrossRefDirect Link

  130. Li, M., R. Huang, X. Zhou, K. Zhang, X. Zheng and R.L. Gregory, 2014. Effect of nicotine on dual-species biofilms of Streptococcus mutans and Streptococcus sanguinis. FEMS Microbiol. Lett., 350: 125-132.
    CrossRefDirect Link

  131. Hutcherson, J.A., D.A. Scott and J. Bagaitkar, 2015. Scratching the surface-tobacco-induced bacterial biofilms. Tob. Induced Dis., Vol. 13.
    CrossRefDirect Link

  132. Kuhn, D.M., J. Chandre, P.K. Mukherijee and M.A. Ghannoum, 2002. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect. Immun., 70: 878-888.
    CrossRefPubMedDirect Link

  133. Sardi, J.C.O., L. Scorzoni, T. Bernardi, A.M. Fusco-Almeida and M.J.S.M. Giannini, 2013. Candida species: Current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J. Med. Microbiol., 62: 10-24.
    CrossRefDirect Link

  134. Staniszewska, M., M. Bondaryk, T. Malewski and M. Schaller, 2014. The expression of the Candida albicans gene SAP4 during hyphal formation in human serum and in adhesion to monolayer cell culture of colorectal carcinoma Caco-2 (ATCC). Open Life Sci., 9: 796-810.
    CrossRefDirect Link

  135. Kucharíková, S., B. Neirinck, N. Sharma, J. Vleugels, K. Lagrou and P. van Dijck, 2015. In vivo Candida glabrata biofilm development on foreign bodies in a rat subcutaneous model. J. Antimicrob. Chemother., 70: 846-856.
    CrossRefDirect Link

  136. di Bonaventura, G., A. Pompilio, C. Picciani, M. Iezzi, D. D'Antonio and R. Piccolomini, 2006. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: Development, architecture, and antifungal resistance. Antimicrob. Agents Chemother., 50: 3269-3276.
    CrossRefDirect Link

  137. Soll, D.R., 1992. High-frequency switching in Candida albicans, Clin. Microbiol. Rev., 5: 183-203.
    CrossRefDirect Link

  138. Hawser, S.P., G.S. Baillie and L.J. Douglas, 1998. Production of extracellular matrix by Candida albicans biofilms. Med. Microbiol., 47: 253-256.
    CrossRefPubMedDirect Link

  139. Laffey, S.F. and G. Butler, 2005. Phenotype switching affects biofilm formation by Candida parapsilosis. Microbiology, 151: 1073-1081.
    CrossRefDirect Link

  140. Pryszcz, L.P., T. Németh, A. Gácser and T. Gabaldón, 2013. Unexpected genomic variability in clinical and environmental strains of the pathogenic yeast Candida parapsilosis. Genome Biol. Evol., 5: 2382-2392.
    CrossRefDirect Link

  141. Phan, Q.T., C.L. Myers, Y. Fu, D.C. Sheppard and M.R. Yeaman et al., 2007. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol., 5: 543-557.
    CrossRefDirect Link

  142. Liu, Y. and S.G. Filler, 2011. Candida albicans Als3, a multifunctional adhesin and invasin. Eukaryotic Cell, 10: 168-173.
    CrossRefDirect Link

  143. Harun, W.H.A.W., N.A. Jamil, N.H. Jamaludin and M.A.F. Nordin, 2013. Effect of Piper betle and Brucea javanica on the differential expression of hyphal wall protein (HWP1) in non-Candida albicans Candida (NCAC) species. Evidence-Based Complementary Altern. Med., Vol. 2013.
    CrossRefDirect Link

  144. Gunasegar, S. and W.H. Himratul-Aznita, 2019. Nicotine enhances the thickness of biofilm and adherence of Candida albicans ATCC 14053 and Candida parapsilosis ATCC 22019. FEMS Yeast Res., Vol. 19.
    CrossRefDirect Link

  145. Dilhari, A., M.M. Weerasekera, A. Siriwardhana, O. Maheshika and C. Gunasekara et al., 2016. Candida infection in oral leukoplakia: An unperceived public health problem. Acta Odontol. Scand., 74: 565-569.
    CrossRefDirect Link

  146. Ye, P., X. Wang, S. Ge, W. Chen, W. Wang and X. Han, 2019. Long-term cigarette smoking suppresses NLRP3 inflammasome activation in oral mucosal epithelium and attenuates host defense against Candida albicans in a rat model. Biomed. Pharmacother., Vol. 113.
    CrossRefDirect Link

  147. Warren, G.W., A.J. Alberg, A.S. Kraft and K.M. Cummings, 2014. The 2014 surgeon generals report: The health consequences of smoking-50 years of progress: A paradigm shift in cancer care. Cancer, 120: 1914-1916.
    CrossRefDirect Link

  148. Mu, K., D. Wang and D.D. Kitts, 2019. Molecular mechanisms that define redox balance function in pathogen-host interactions-is there a role for dietary bioactive polyphenols? Int. J. Mol. Sci., Vol. 20.
    CrossRefDirect Link

  149. Kansanen, E., S.M. Kuosmanen, H. Leinonen and A.L. Levonen, 2013. The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer. Redox Biol., 1: 45-49.
    CrossRefDirect Link

  150. Ahmed, S.M.U., L. Luo, A. Namani, X.J. Wang and X. Tang, 2017. Nrf2 signaling pathway: Pivotal roles in inflammation. Biochim. Biophys. Acta, Mol. Basis Dis., 1863: 585-597.
    CrossRefDirect Link

  151. Cui, W., Z. Zhang, P. Zhang, J. Qu and C. Zheng et al., 2018. Nrf2 attenuates inflammatory response in COPD/emphysema: Crosstalk with Wnt3a/β‐catenin and AMPK pathways. J. Cell. Mol. Med., 22: 3514-3525.
    CrossRefDirect Link

  152. Ye, P., W. Chen, F. Huang, Q. Liu and Y.N. Zhu et al., 2021. Smoking increases oral mucosa susceptibility to Candida albicans infection via the Nrf2 pathway: In vitro and animal studies. J. Cell. Mol. Med., 25: 7948-7960.
    CrossRefDirect Link

  153. Vonk, A.G., M.G. Netea, J.H. van Krieken, Y. Iwakura, J.W.M. van der Meer and B.J. Kullberg, 2006. Endogenous interleukin (IL)–1α and il‐1β are crucial for host defense against disseminated candidiasis. J. Infect. Dis., 193: 1419-1426.
    CrossRefDirect Link

  154. Kobayashi, E.H., T. Suzuki, R. Funayama, T. Nagashima and M. Hayashi et al., 2016. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat. Commun., Vol. 7.
    CrossRefDirect Link

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved